Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy EPG2026

Vertex Pharmaceuticals Inc.
Start price
€34.73
27.01.13 / 50%
Target price
€40.00
19.04.13
Performance (%)
85.13%
End price
€64.30
19.04.13
Summary
This prediction ended on 19.04.13 with a price of €64.30. With a performance of 85.13% the BUY prediction by EPG2026 was a big success. EPG2026 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Vertex Pharmaceuticals Inc. -1.465% -1.465% 3.309% 29.044%
iShares Core DAX® 2,59 % 2,69 % 6,41 % 53,61 %
iShares Nasdaq 100 -0,91 % -7,37 % 20,65 % 72,78 %
iShares Nikkei 225® 0,15 % -10,20 % 46,17 % 62,43 %
iShares S&P 500 -0,37 % -0,83 % 18,02 % 60,74 %

Comments by EPG2026 for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 85.13%
Target price 40.000
Change
Ends at 19.04.13

Sehr gute Biotechaktie

Vertex Pharma hat gute Produkte in der Pipeline

EPG2026 
0
Report Share
27.01.13
Prediction Buy
Perf. (%) 85.13%
Target price 40.000
Change
Ends at 19.04.13

(Vom Mitglied beendet)

EPG2026 
0
Report Share
19.04.13